Revisor Wealth Management
WST icon

Revisor Wealth Management’s West Pharmaceutical WST Stock Holding History

Revisor Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$382K Sell
997
-125
-11% -$44.1K 0.09% 226
2026
Q2 		$403K Sell
1,122
-152
-12% -$46.5K 0.1% 230
2026
Q1 		$318K Buy
1,274
+205
+19% +$51K 0.09% 242
2025
Q4 		$265K Sell
1,069
-98
-8% -$26.8K 0.07% 259
2025
Q3 		$306K Sell
1,167
-380
-25% -$92.4K 0.11% 207
2025
Q2 		$354K Buy
1,547
+144
+10% +$30.8K 0.13% 193
2025
Q1 		$314K Buy
1,403
+768
+121% +$212K 0.14% 163
2024
Q4 		$208K Sell
635
-401
-39% -$126K 0.19% 116
2024
Q3 		$311K Buy
1,036
+69
+7% +$21.1K 0.19% 121
2024
Q2 		$319K Sell
967
-542
-36% -$192K 0.22% 107
2024
Q1 		$564K Buy
1,509
+750
+99% +$277K 0.26% 104
2023
Q4 		$267K Sell
759
-287
-27% -$102K 0.31% 91
2023
Q3 		$392K Buy
1,046
+289
+38% +$112K 0.33% 69
2023
Q2 		$290K Sell
757
-168
-18% -$60K 0.26% 109
2023
Q1 		$320K Buy
+925
New +$270K 0.29% 85

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Revisor Wealth Management's WST Position: Q3 2026 in Review

Revisor Wealth Management reduced its West Pharmaceutical (WST) stake by 11% in Q3 2026, selling an estimated $44.1K and leaving 997 shares worth $382K. The position accounts for 0.09% of the portfolio, ranked #226.

Revisor Wealth Management first reported a position in WST in Q1 2023 and has held it in 15 quarters since. The position peaked at $564K in Q1 2024. 156 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Revisor Wealth Management held 997 shares of West Pharmaceutical worth $382K as of Q3 2026.
  • Revisor Wealth Management sold 125 West Pharmaceutical shares in Q3 2026, an estimated $44.1K.
  • West Pharmaceutical made up 0.09% of Revisor Wealth Management's portfolio in Q3 2026, its #226 holding.
  • Revisor Wealth Management first reported a position in West Pharmaceutical in Q1 2023 and has held it in 15 quarters since.
  • Revisor Wealth Management's West Pharmaceutical position peaked at $564K in Q1 2024.
  • 156 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Revisor Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.